We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




ddPCR Developed for BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia

By LabMedica International staff writers
Posted on 12 Jan 2022
Droplet digital polymerase chain reaction (ddPCR) is a novel polymerase chain reaction (PCR) technique reliant on massive sample partitioning to generate individual reaction chambers (droplets) in which individual amplification targets are detected.

Standardized measurements of BCR-ABL1 p210 translocation by RT-qPCR assays for chronic myelogenous leukemia have proved challenging because of various sources of error including processing of specimens, reference gene selection, the reverse transcriptase reaction, and quantification of transcripts.

Medical Scientists at the University of Minnesota (Minneapolis, MN, USA) obtained clinical samples from specimens from patients who had been previously tested for BCR-ABL1 p190 transcript in the molecular diagnostics laboratory. More...
Samples consisted of both bone marrow and peripheral blood. All samples were stored at −80 °C. The scientists’ aim was to compare results of ddPCR and RT-qPCR BCR-ABL1 fusion transcript measurements of patient samples and determine if either method is superior.

RNA was isolated with the Maxwell RSC simplyRNA Blood Kit and Maxwell RCS instrument (Promega, Madison, WI, USA). The clinical RT-qPCR assay was performed using the TaqMan Reverse Transcription and TaqMan Universal PCR Master Mix (Applied Biosystems, Waltham, MA, USA). Droplet digital PCR was performed using the One-Step RT-ddPCR Advanced Kit for Probes and for automated studies, the QX200 AutoDG system (Bio-Rad Laboratories, Hercules, CA, USA). The PCR was performed in a Bio-Rad C1000 Touch thermal cycler.

The investigators reported that droplet digital polymerase chain reaction was able to detect the BCR-ABL1 p190 transcript to 0.001% (1:10−5) with a calculated limit of detection and limit of quantitation of 4.1 and 5.3 transcripts, respectively. When tested on patient samples, ddPCR was able to identify 20% more positives than a laboratory-developed 2-step RT-qPCR assay. Of the 101 samples measured, 65 samples with a previously positive p190 transcript and sufficient RNA for analysis were further analyzed. Thirty-five of 65 samples (54%) were measured as positive by both methods, and the BCR-ABL1:ABL1 ratio was compared. The majority of samples showed concordant results between the two methods, but several samples demonstrated discordant quantification.

The authors concluded that droplet digital polymerase chain reaction demonstrated increased detection of BCR-ABL1 compared with RT-qPCR. Improved detection of BCR-ABL1 p190 and the potential for improved standardization across multiple laboratories makes ddPCR a suitable method for disease monitoring in patients with acute B-lymphoblastic leukemia. The study was published in the January, 2022 issue of the journal Archives of Pathology and Laboratory Medicine.

Related Links:
University of Minnesota
Promega
Applied Biosystems
Bio-Rad Laboratories



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: The Fast PCR System delivers sample‑to‑answer results for key pathogens in under 10 minutes (Photo courtesy of Autonomous Medical Devices Incorporated)

Point-of-Care PCR Panel Detects RSV, Influenza, and SARS-CoV-2 in Minutes

Respiratory syncytial virus, influenza, and SARS-CoV-2 remain major respiratory pathogens in ambulatory care. RSV is a particular priority because it can cause significant disease in infants, older adults,... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.